Retrospective transfusional audit at the centro nacional de la transfusión sanguínea;Auditoría transfusional retrospectiva en el centro nacional de la transfusión sanguínea

Revista de Investigacion Clinica

Volumn 56, Issue 1, 2004, Pages 38-42

  Juárez Rangel, Eduardo ^a   Vite Casanova, Ma Jezabel ^a   Marín y López, Rafael A ^a   Sánchez Guerrero, Sergio A ^a  

^a Ctr Nacl de la Transfus Sanguinea   (Mexico)

Author keywords

Blood products; Iatrogenia; Transfusion therapy; Transfusional audit

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN; THROMBOCYTE CONCENTRATE;

ANEMIA; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION;

BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; GUIDELINE ADHERENCE; HUMANS; MEDICAL AUDIT; RETROSPECTIVE STUDIES;

EID: 18244421632     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sazama K, DeChristopher P, Dodd R, et al. Practice parameter for the recognition, management and prevention of adverse consequences of blood transfusion. Arch Pathol Lab Med 2000; 124: 61-70.
2. British committee for standards in hematology, blood transfusion task force in collaboration with the Royal College of Nursing and the Royal College of Surgeons of England. The administration of blood and blood components and the management of transfused patients. Trans Med 1999; 9: 227-38.
3. García J, Rodríguez P, Bernal T, et al. Adecuación de la transfusión de hemoderivados a criterios previamente establecidos. Sangre 1996; 41(1): 19-23.
4. Wilson K, MacDougall L, Fergusson D, et al. The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature. Transfusion 2002; 42: 1224-9.
5. American Association of Blood Banks. America's Blood Centers and the American Red Cross. Circular of information for the use of human blood and blood components 2002; 1-42.
6. NIH consensus development conference. Fresh Frozen Plasma: indications and risks. JAMA 1985; 253: 551-3.
7. NIH consensus development conference. Platelet Transfusion Therapy. JAMA 1987; 257: 1777-80.
8. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84(3): 732-47.
9. Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997; 156(S1): S1-23.
10. Simon T, Alverson D, AuBuchon J, et al. Practice parameter for the use of red blood cell transfusion. Arch Pathol Lab Med 1998; 122: 130-8.
11. British Society for Haematology. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113(1): 24-31.
12. Malagón A. Consenso Nacional para el uso de sangre y sus componentes. Gac Med Mex 2002; 138(Suppl. 1): S35-7.
13. Méndez I, Namihira D. Analisis estadistico. En: El Protocolo de Investigación. 2a. edición México, D. F.: Editorial Trillas; 2000, p. 128-30.
14. Silberstein LE, Kruskal MS, Stehling LC, et al. Strategies for the review of transfusion practices. JAMA 1989; 13: 1993-7.
15. Tuckfield A, Haeusler M, Grigg A, et al. Reduction of inappropriate use of blood products by prospective monitoring of transfusion request forms. Med J Aust 1997; 167: 473-6.
16. Pita L, Cabrera B, Ortega C. Motivos de transfusión de plasma fresco congelado en un hospital general. Rev Invest Clin 1999; 51: 89-92.